Introduction

“If you think competition is hard, you should try collaboration” (Kings Fund Report, 2019)

Over the past decade, there has been wide international concern that new health research and evidence is not translated into practice in a timely fashion [1, 2]. The 17-year time lag between evidence and clinical practice change has been widely touted [3]. Systemic barriers such as lack of integration between health and research, dissonant metrics, organisational and professional silos, pervasive competition, lack of collaboration, and a failure to engage relevant stakeholders have all been identified as contributors to translation ‘gaps’ [4,5,6]. An international response to accelerate the translation and mobilisation of new knowledge has been the development of large-scale partnerships between universities, research institutes and health services that aim to integrate healthcare, research and education [7]. In world-leading United Kingdom and Australian health systems [8], these partnerships include a focus on evidence translation and health impact.

In England, these ‘partnerships’ include Collaboration for Leadership in Applied Health Research Centres (CLAHRCs), Academic Health Science Centres (AHSC) and Academic Health Science Networks (AHSNs). Collectively, these entities are often referred to as Research Translational Centres (RTCs) and they have been established internationally in the United States, Canada, England and Australia. In 2008, the National Institute for Health Research (NIHR) established nine CLAHRCs to increase the uptake of promising clinical research into practice and improve outcomes by engaging service users and the public in applied health research [9]. CLAHRCs competed with each other for NIHR funding in 5-year cycles. Subsequently, AHSCs were established in 2009. They are not formally part of the NIHR and, unlike CLAHRCs, did not receive NIHR funding [9]. These centres originally developed through interactions between rival institutions and occurred in a policy context that supported and accredited a limited number of prestigious AHSCs that continue to operate in strong institutional competition [10].

In 2013, a second round of competitive CLAHRC funding saw the recognition of 13 centres across England. Simultaneously, AHSNs were established with clear structures of accountability and budget and a focus on promoting and adopting innovation in healthcare. Commissioned by the National Health Service (NHS), concerns that the future of these networks may be constrained by budgetary pressures have been expressed [11], even though improving the uptake of innovation is valued in improving the quality and sustainability of healthcare in England. CLAHRCs were tasked with strengthening collaborations with the AHSNs [9]. A third round of CLAHRC funding, announced in 2019, saw the centres renamed as Applied Research Centres (ARCs), with increased focus on social care and public health. Strengthening the links between the ARCs and the AHSNs remains a priority, with AHSNs expected to take up and implement evidence generated by the ARCs.

In Australia, the McKeon review (2013) identified that the best performing health systems are those that embed research in healthcare and recommended the establishment of integrated RTCs that combine hospital networks, universities and medical research institutes [12]. The review also recommended a doubling of investment in medical research to grow applied health research that drives efficiency and impacts on communities. Since 2015, the National Health and Medical Research Centre (NHMRC) has accredited seven Advanced Health Research Translation Centres and three Centres for Innovation in Regional Health (CIRHs) to encourage leadership in health research and implementation [13]. The accreditation process is competitive to a benchmark but RTCs do not compete against each other. The Advanced Health Research and Translation Centres and CIRHs are, to some extent, modelled on RTCs elsewhere, including England, but are uniquely ‘health service-led’ collaborations. The CIRHs have a specific focus on the healthcare needs of regional and remote Australian populations.

Another unique feature of the RTCs in Australia is that they have developed a national alliance – the Australian Health Research Alliance (AHRA). The Australian Federal and State Governments have since invested in these RTCs across the AHRA. Funds are shared equally across all RTCs accredited by the NHMRC and, hence, the system enables collaboration for greater benefit from existing funding rather than promoting competition. The AHRA has increasingly prioritised research on RTC operations and activities, including how best to mobilise strategic prioritised health research in practice and how to measure and capture impact. This is because, despite significant government investment, the optimal collaboration models and activities are yet to be fully understood, especially in Australia where the RTCs and AHRA are relatively recent constructs. In England, several evaluations of the CLAHRCs and AHSCs have been undertaken [9, 14,15,16] but these have mostly been internal evaluations and limited in scope. Given that both England and Australia have world-leading universal health systems [8] and that the recently established Australian centres are modelled on the English centres, a rapid review of RTCs (confined to England and Australia) was conducted to inform the ongoing development of these partnerships.

This rapid review is timely, with the CLAHRCs and AHSNs in England focusing on greater collaboration and the Australian centres recently being funded $300 million over 10 years, with a clear need for more research to guide evolution. Knowledge ‘gaps’ identified by Australian RTCs include workforce development, strategies for consumer and community involvement (CCI), optimal collaborations, governance arrangements and structures to drive collaboration. CCI and workforce development needs are diverse, yet here we focus on strategies aligned with the RTCs’ aim to integrate research and healthcare and to build collaborations and drive evidence-based healthcare improvement.

Methods

Rapid reviews have emerged as an efficient way of supporting health policy-making and systems development by providing evidence in a timely and cost-effective fashion [17]. They employ a wide variety of methods [18] and, although we acknowledge that rapid and limited evidence searches can lead to missed information, these methods were chosen as pragmatic and timely and because they capture both academic and grey literature. Traditional systematic review processes were not amenable to the time-frame required by our health partners (the AHRA) and would not capture the diverse reports and evaluations found largely in the grey literature, although it is acknowledged that the grey literature is not rigorously peer reviewed and that combining published and grey literature may lead to bias [19]. However, rapid reviews do meet the needs of end-users in addressing emerging issues within limited time-frames.

The scope of this review included the vision, governance and structure of RTCs, their CCI, (public and patient involvement (PPI) in England), and workforce development strategies. This review included published academic and grey literature with a customised search of the Google search engine and RTC websites. Since abstracts were unavailable for reports in the grey literature, executive summaries, recommendations and table of contents were reviewed. We searched for academic publications in EMBASE and SCOPUS databases using the following search terms: “Collaboration for Leadership in Applied Health Research and Care” OR “Academic Health Science Centre*” OR “Academic Health Science Network*” OR “Advanced Health Research and Translation Centre*” (acronyms were excluded, as they failed to yield results). In terms of the grey literature, the above terms linked to “AND evaluation” were searched on Google, then sorted by relevance. We also searched the websites of RTCs in England and Australia.

The search period was limited to the previous 10 years (2008 to August 2019) to ensure currency of our findings in a landscape where RTCs continue to evolve. Inclusion criteria for the published and grey literature included reports or evaluations that addressed structure, governance, community and consumer engagement, and/or workforce development. Although the heterogeneity of grey literature means it is less amenable to traditional forms of analysis, it did extend the scope of findings by incorporating information on the applied topic areas and by filling gaps that were apparent in the academic literature. Permission to conduct this study was received from the Monash University Human Research Ethics Committee.

Results

A search of EMBASE and SCOPUS identified a total of 272 relevant papers (after duplicates removed) over 10 years (2008 to August 2019). A review of titles and abstracts identified 41 scientific papers for consideration, all of which addressed the evaluation domains of interest and were retained after full-text review, as shown in the PRISMA diagram in Fig. 1. This included one systematic review of CLAHRC evaluations [20] but no evaluations of RTCs in Australia. The evaluations of CLAHRCs were diverse, and often descriptive and exploratory in nature with a paucity of evidence about the overall impact of centres, particularly in relation to knowledge mobilisation processes [20]. Of the evaluations reviewed, most focused on partnerships, structures and processes. Likewise, a scoping review of AHSCs found most of the literature to be descriptive case studies or commentaries [7]. This highlights the challenges involved in evaluating complex systems that may require different methods (such as social network analysis) to better capture their dynamics [20]. The grey literature and review of all RTC websites provided additional information specific to each centre.

Fig. 1
figure 1

PRISMA diagram

Full size image

RTCs’ vision, governance and structure

Although RTCs share a common aim to integrate research and training with health services, there was considerable variation in their vision, governance and structure in both countries. In England, the CLAHRCs have a declared mission to support high-quality applied research that meets the needs of local health and care systems [21], yet there was considerable variation across individual centres. Table 1 demonstrates that collaboration for patient benefit, translation and the harvesting of evidence were commonly identified in the vision statements for CLAHRCs, while the AHSNs had a focus on innovation as a key part of their mission. The AHSNs were created to connect the NHS and academic organisations, local authorities and industry with a clear focus on improving patient outcomes [22]; they aim to foster opportunities for industry to work effectively with the NHS by leading regional networks and generating economic growth in their regions. The AHSCs in England share a similar aim to improve health education and patient care and are commonly ‘nested’ within an AHSN but their focus is more on research excellence and the translation of new innovation from the laboratory to the bedside. Governance structures in England appear well developed, albeit highly variable. Most RTCs had all partners represented on their governing boards, with specific steering, advisory and PPI committees. The AHSNs reported over-arching executive boards with discrete advisory committees that help define and advise on regional issues and the inclusion of clinical commissioning groups in their governance. The governance and structure of AHSCs was variable – some reported having academic leaders who determined themes, while others reported having equal representation from all partners.

Table 1 Website search of centres: vision, structure and governance, community engagement and workforce capacity-building
Full size table

The stated vision of RTCs in Australia emphasised the integration of research with healthcare and partnerships. The translation of evidence was a strong and consistent focus, largely funded by the Medical Research Future Fund (MRFF) that provides grants for rapid applied research translation [23]. Early funding priorities have been identified by the MRFF and include reducing unwarranted variation, improving clinical pathways, improving the health of vulnerable groups, increasing primary care research and reducing risk factors for chronic diseases [23]. In terms of their structure and governance, RTCs in Australia appeared to have more consistency, with all partners represented on boards or councils and various advisory, translation or management committees. Healthcare leadership (rather than academic) was a key feature of Australian RTCs as a means of enhancing the accountability, relevance and impact of research. This governance structure is challenged by the fact that universities are federally funded, whereas healthcare is funded by state governments [24]. However, this is being addressed by the fact that both the RTCs and the AHRA are federally funded. One RTC in Australia has a unique ‘bottom up’ structure, where governance is strongly led by Aboriginal community controlled organisations and Aboriginal ‘voice’ is embedded across all levels of the organisation (the Central Australian Academic Health Science Network). Few RTCs in either country report on their websites how their vision or governance was developed or whether a strategic plan was in place.

In terms of structure, or the ‘architecture’, some RTCs were built around clinical themes (largely disease focused with flagship programmes), with some being structured around platforms or fields of work such as public health and health services. In England, leading figures with particular research experience acted as Directors and many centres reported having a three-tier structure with a Board, management committee and working groups that align with the clinical themes/projects. While RTCs in both countries identified diverse clinical themes, few reported information on how they developed priorities for themes or whether they involved collaborations with services users and healthcare providers to inform structures and processes.

3.2. Workforce development

The review identified that workforce capacity is being developed across the system, organisation and individual levels to build capacity in translational research and healthcare improvement. This requires leaders with broader skills and support to operate across organisational boundaries and address system-level barriers to change. In England, national efforts to develop leadership include the NHS Leadership Academy and NHS Horizons, which collaborate to identify future leadership development directions [25]. While the Horizons team supports leaders of change, the Leadership Academy provides a range of tools, models and programmes to support individuals and organisations to develop leaders [26]. In Australia, there is no coordinated national effort but some initiatives are emerging. In this context, Table 1 demonstrates that RTCs in both countries are all undertaking workforce capacity-building. At the individual level, diverse training needs were identified, including research and data skills, CCI and translation literacy.

The literature confirms the focus on and importance of skills in implementation research, knowledge mobilisation, evaluation skills and collaborative priority-setting with potential end-users of research [3, 27]. Time and space are needed to build effective collaborations and, while the ARC model did facilitate collaborative priority-setting, Cooke et al. [27] reported that scant knowledge exists about processes or guidance on how best to achieve meaningful collaboration. Platforms for negotiation and decision-making (such as special interest groups and advisory groups) were possible enabling factors, as were formal consensus methods for priority-setting [27]. In England, the James Lind Alliance brings patients, carers and clinicians together to identify research priorities [28]. In Australia, Delphi and Nominal Group Techniques have been adapted and used for eliciting priorities across stakeholders [29, 30].

In England, an important organisational workforce enabler for meaningful engagement, embedding research into healthcare and the translation of new evidence, was leadership. Leadership was identified as a key factor in the overall success of RTCs, including in their workforce capacity for knowledge mobilisation [20, 31,32,33]. Currie et al. [33] stressed the importance of understanding the social position of senior members of CLAHRCs. Although well-known clinical academics are likely to lead the centres, this study found that privileging pre-existing relationships may constrain much-needed change and meaningful engagement with service users and frontline clinicians [33]. Leadership in CLAHRCs has been enacted in three ways: ‘push’ models for top down leadership that focus on technical infrastructure, pull methods that aim to increase leadership capacity among project leads and more collective approaches that dispersed leadership to drive new relations between academia and clinical practice [32]. Aligned with this, a recent Kings Fund report highlights the importance of system leadership (being comfortable with chaos) in driving meaningful change [6].

Although dispersed leadership approaches were crucial for the exchange of new knowledge, push and pull models continued to influence how knowledge was ‘moved’ within CLAHRCs, especially in relation to the development of technical infrastructures and translating knowledge at the project level [32]. While more distributed models of leadership were associated with increased potential for engagement with the CLAHRCs [20], a longitudinal realist evaluation of three centres found that a blend and alignment of designated leadership with distributed leadership was a necessary condition for collective action and implementation [34]. The presence of both these leadership styles appeared to be important for ensuring alignment and integration across streams [34]. As such, workforce development in leadership appears important in the context of RTCs.

The need to move knowledge across professional ‘silos’ resulted in several RTCs creating new system approaches such as knowledge-brokering roles (although they varied considerably across centres) [20, 35,36,37,38]. For example, some deployed ‘diffusion fellows’, who were senior health staff seconded to actively bridge the research–practice gap [35]. Despite showing much promise, knowledge brokering and other hybrid roles were often unrecognised and lacked support within their organisations [39, 40]. Although management theory identifies that knowledge mobilisation relies on relationships and is an inherently social undertaking [9, 41], the deployment of hybrid roles as a means of overcoming system barriers requires particular capabilities and was found to be challenging [20]. Nevertheless, workforce capabilities, such as stakeholder engagement, co-design, collaboration and team-work, and the co-production of knowledge, rely on understanding complexity and working across multiple levels (individual and organisational) to enact new knowledge [42]. The importance of developing skills for mobilising knowledge across disciplines and different users was confirmed in the literature [27, 33, 43,44,45,46,47]. Mobilising knowledge that is multidisciplinary requires different communities to interact [15] and RTCs are well placed to enable this kind of cross-silo collaboration, including with health, business, IT, social sciences, engineering and other disciplines.

Individual workforce capabilities for supporting RTC endeavours are not all technical and may include observational skills, appreciative inquiry, systems thinking, improved understanding of data, distributive or collective leadership, and quality improvement – all of which are increasingly found in English workforce programmes but are not yet incorporated into workforce programmes in Australia. At the level of the system and organisation, key workforce development approaches identified in this review include leadership and mentoring [48], processes for stakeholder engagement [27], and the creation of new hybrid roles to move knowledge across discipline and organisational boundaries. Despite a focus on leadership, the evaluation of three CLAHRCs by Rycroft-Malone et al. [49] identified that, on balance, they tended to conduct research rather than focus on ‘how’ to use and apply new research evidence. This means that closing the knowledge–practice gap and methods for translating evidence into improved patient outcomes are yet to be clearly established [49]. However, AHSNs are now more aligned with the CLAHRCs to increase the translation of generated evidence.

CCI (Australia) and PPI (England)

One significant difference between Australian and English centres was the latter’s strong focus on PPI. England has a national PPI strategy, with PPI a policy and funding requirement and a key strategy for situating patients at the centre of research and healthcare improvement [27]. The importance of PPI in healthcare has been acknowledged for some time in England; however, there is still limited research on the optimal methods for driving and enabling PPI [34, 50]. The literature highlights a significant gap in understanding how PPI can inform implementation research that often focuses on the behaviour of health professionals and health systems and policies (as opposed to clinical research) [34]. Despite significant advancement in England, cultural barriers persist, including the narrowness of PPI models that fail to address empowerment, equality or diversity strategies [51]. Often, the level of PPI operates more as consultation rather than as active co-production and empowerment.

Other processes for authentic PPI enshrined in all CLAHRCs include providing payment for PPI representatives to attend meetings and training to enable more informed and active participation. The provision of training and remuneration for PPI representatives is a significant difference between England and Australia; however, real progress in PPI in England cannot be realised without an effective mechanism for coordinating efforts across the complex network of organisations that comprise the NIHR [51]. The systematic review conducted by Kislov et al. [20] reported that none of the NIHR-funded evaluations had a particular focus on PPI, although one included interviews with PPI representatives [9] and three investigated how PPI was enacted [52,53,54]. These evaluations all acknowledged the difficulties of quantifying PPI elements and Marston and Renedo [52] recommend the inclusion of patient voices and tracking dynamic social processes and networks to better understand the key elements and impact of PPI. It is important to identify the dynamic processes and networks through which PPI can contribute to healthcare improvement efforts [20] as well as the key time-points and strategies for PPI to have the most impact in the translational research cycle [51].

In Australia, only three RTCs included dedicated information on CCI on their websites. However, across all RTCs, the AHRA have prioritised CCI as a national system-level initiative and have developed a CCI strategy with key stakeholders and completed both an environmental scan of the literature and a national survey on the extent and nature of CCI. In 2018, a national workshop was convened to prioritise the next steps and RTCs committed funding and staff to collaboratively progress this work. To date, findings from Australia confirm that CCI is complex (consistent with the English experience) and that the locus of control for involvement in Australia remains largely with researchers [55]. The AHRA report also identified a need for more resourcing and better policy aligned with England. They recommended a range of strategies to promote and explore the value and impact of CCI. This report included the development of minimum standards for good practice in CCI involvement in RTCs and guidance on how to incorporate it across the research life cycle [55], alongside training and capacity-building. Currently, the report recommendations are being implemented collaboratively and co-ordinated nationally through the AHRA.

Discussion

This review explored the visions, structures and governance processes of RTCs, their workforce development activities and CCI/PPI as key factors for integrating research with health service and community needs. Centres in both England and Australia share a common architecture in that they generally have boards that represent all partners and are organised along research themes that reflect their research strengths, with cross-cutting platforms to enable collaboration with health services. In terms of their vision, RTCs in England appear to have a greater research focus on innovation (AHSNs), collaborative and applied research (CLAHRCs), and a traditional push model of discovery and clinical research into practice (AHSCs). In Australia, RTC visions are aligned with translation, partnerships, and impact and have a strong and consistent focus on research translation.

In terms of workforce development (aligned with RTC visions to integrate research into healthcare, build collaboration and drive evidence-based healthcare improvement), leadership was a key enabling factor. Given that they are an amalgam of stakeholders with potentially competing demands, it is perhaps not surprising that leadership is a prominent theme. Leadership approaches appear to require both dispersed and distributed or top-down and bottom-up approaches to facilitate working collectively with multiple stakeholders [32, 36]. Collective and distributed leadership approaches have also been shown to enable healthcare improvement and transformational change [32, 56, 57]. Evaluation reports and published literature identified knowledge mobilisation as another key workforce skill for evidence translation. Historically, the evidence translation gap was perceived as a practice/service responsibility and challenge, rather than a problem of implementation or knowledge creation [34]. This highlights the need for systems approaches with a more nuanced understanding of how knowledge moves and can be brokered within complex organisations to enable improvement.

In England, structural solutions, such as the creation of new hybrid roles, has proved challenging – particularly in relation to working across all levels of complex organisations and diverse contexts [58,59,60]. However, skills and capabilities for moving knowledge in healthcare organisations were identified, including process and systems thinking, the involvement of stakeholders, change management, facilitation, negotiation, and advocacy skills [34, 61]. These are yet to find their way into traditional healthcare innovation and knowledge mobilisation roles, where the focus is often organisational and inward looking rather than collaborative with stakeholders and engaging with external evidence [40]. At this stage, workforce capacity development is more developed in English centres compared with Australia. However, Australian RTCs are now working together with nationally coordinated efforts to improve and scale workforce development activity.

Likewise, in England, PPI is well established and embedded in policy and funding requirements, although there is also a recognition that optimal processes for PPI and their impact should be better understood [14,15,16]. When utilised effectively, PPI appears to have the potential to transform services and address the research–practice divide [62, 63], but it is important to research and translate how patient input can be best integrated at all levels within and between RTCs. In England, funding, dedicated staff and training are available for both PPI members and frontline staff with co-design and co-production with stakeholders; this is not yet mirrored in Australia, where training programmes for the public and service users are emerging but remain under-developed. However, the AHRA has strongly prioritised and developed a national framework and is focusing on a coordinated approach to CCI. Funding bodies encourage but do not require CCI. One RTC in Australia, with community controlled Aboriginal health service members, appears to be leading in terms of processes for community engagement and clinical and corporate governance participation. Further research and evaluation are needed on the optimal methods and impact of CCI in research and healthcare improvement.

Overall, the findings from this review are important for the evolving RTCs in Australia, which are relatively young organisations and are due for re-accreditation by the NHMRC in 2022. Although this review focused on the structures, leadership, workforce development and engagement with communities of RTCs, it is important to acknowledge that these highly complex interventions, with their relational interactions and processes for collaboration, are often poorly captured and articulated in the literature. In order to understand these nuances, qualitative research is warranted as a means of capturing the range of activities and outcomes generated by these collaborative platforms. Australia has yet to evaluate their RTCs but it is notable that the Australian government has recently committed a 10-year funding strategy, which validates the perceived potential and importance of these entities and provides for long-term strategic planning. It also mandates more evidence-based approaches and the need for evaluation. The Australian MRFF was announced as part of the 2014–2015 federal budget and will build to a $20 billion perpetual fund over the next decade [64]. The MRFF scheme will complement and enhance current research funding schemes but will focus on delivering a health system fully informed by research with community and patient impact [65]. This approach is supportive of RTC visions and directly aligns with strategic prioritised research rather than conventional investigator-led research [66]. This is important because the systematic review of CLAHRC evaluations identified that 5-year funding cycles in England were insufficient to foster and embed collaborations between academic and service providers [20].

In Australia, the AHRA has prioritised streamlining and the consistency of structures and processes, whilst respecting regional differences. This Australian collaboration is possible in the context of avoiding direct competition for accreditation or funding. This has enabled a more collaborative approach to challenges and coordinated activities nationally within and between centres. This is consistent with recommendations from England that more research is needed that focuses on how collaboration occurs between RTCs [16] and with the recent Kings Fund report [6] on the vital need for more collaboration and less competition in healthcare improvement.

RTCs are complex system-level interventions that will need to disrupt the current paradigms and silos inherent in healthcare, education and research in order to meet their aims. This is likely to require vision, leadership, collaborations and shared learnings, alongside structures, processes and strategies to deliver impact in the face of complexity. The impact of RTCs in overcoming the deeply entrenched silos across organisations, disciplines and sectors needs to be captured at the systems, organisation and individual levels. Collectively, the creation of structures and streamlined processes to accelerate stakeholder engagement and collaboration, evidence synthesis, knowledge transfer, data systems and the effective integration of implementation and improvement into healthcare are the holy grail of RTCs. However, many centres appear to still focus on clinical themes and siloed projects. As these RTCs mature, capturing and learning effective ways to promote system change will rely on capturing higher level learnings from the plethora of RTC projects.

This includes better understanding of how to strategically prioritise research and how to build the capacity of the workforce to translate new knowledge into action. Recently, RTCs have developed novel ways of demonstrating these processes, including the use of ‘casebooks’ that detail the impact of research on NHS practice [67]. A consistency of purpose and activity is needed, alongside a focus on regional needs. Associated policy intentions and funding objectives that support shared learnings and collaborations are also important. Regardless of how RTCs are structured or where they are situated, these collaborative entities all share common potentials and challenges, mostly around how to collaborate in a siloed and competitive system and how to ensure that research and service delivery are integrated and evidence generated and translated for the benefits of the community they serve.

Limitations

This rapid review synthesises diverse literature about broad and complex collaborative RTCs that have become key entities in policy and healthcare service improvement. Combining diverse information sources is challenging and, in the current review, may have limited the depth of findings. Although rapid reviews allow for the inclusion of grey literature, it is important to acknowledge that optimal methods for conducting these reviews are evolving and are yet to be determined. These reviews may lack rigour even while they may prove more viable in terms of cost, timeliness and the breadth of information accessed. However, there is a growing recognition that an understanding of systems perspectives and their inherent complexity require reviews from diverse sources and are not always well served by traditional approaches such as those afforded by systematic reviews [68]. The review only focuses on England and Australia as world leading universal health systems with strong policy and funding commitment to the integration of research and healthcare, evidence-based improvement and RTCs.

Conclusions

A challenge for all RTCs is how to integrate research and healthcare and overcome competition to build collaboration and deliver impact. The English experience highlights that this requires a better understanding of the structure and vision of centres, their workforce capacity needs, and the nature of their collaborations with service users and communities. Although workforce capacity-building and the involvement of consumers and the community are more developed in England, the development of an alliance between centres in Australia is providing a platform for national coordination, shared learning and rapid collaborations. This alliance has facilitated and shared a national agenda in a range of areas. Given that the development and funding of RTCs represents one of the most significant shifts in the health research landscape, it is imperative that we continue to explore how we can progress the integration of research and healthcare and ensure that research meets stakeholder needs and is translated via the collaborations supported by these organisations.